In addition, since longitudinal screening is superior to single threshold CA125 measurements for ovarian cancer screening in average-risk women, easily accessed point-of-care CA125 measurements can be used to facilitate more effective longitudinal screening [176]. The gene discussed is MUC16; the disease is ovarian carcinoma.